by The Prepacked Chromatography Columns market is estimated to be valued at US$ 307.6 Mn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period from 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Prepacked chromatography columns contain pre-packed chromatography medium and are pre-filled with resins for quick and efficient purification of biomolecules. They minimize tedious packing procedures and save time during chromatography processes. These columns are widely used in the biopharmaceutical industry for downstream processing of biotherapeutics during drug development and manufacturing.
Market Dynamics:
Growing demand for monoclonal antibodies and therapeutic proteins is expected to drive the growth of the prepacked chromatography columns market over the forecast period. Monoclonal antibodies and recombinant proteins are in high demand for treatment of various chronic diseases like cancer. According to World Health Organization (WHO), chronic diseases accounted for approximately 60% of all deaths globally in 2020. Furthermore, growing acceptance of biologics over traditional pharmaceutical drugs due to their high target selectivity and efficacy is also propelling the market growth. However, high costs associated with these columns and requirement of skilled professionals for their operation can hamper the market growth.
SWOT Analysis
Strength: Prepacked chromatography columns offer convenience and consistency as they come pre-packed and ready-to-use. This saves time during complex purification steps. They provide optimized performance and reproducible results for chromatographic applications. Being prepacked also reduces manual errors during packing.
Weakness: Prepacked columns are more expensive compared to conventional column packing methods. Their stationary phases also have less capacity and lifetime compared to columns that are packed on-site.
Opportunity: Rising R&D investments in pharmaceutical and biotechnology industries is driving the demand for prepacked columns for process development and purification applications. Growing biologics market also presents an opportunity for market growth.
Threats: Availability of cheaper bioseparation techniques is a threat as it may replace chromatography for certain applications. Stringent quality norms and regulations also increase production costs.
Key Takeaways:
The global Prepacked Chromatography Columns Market Size is expected to witness high growth, exhibiting CAGR of 7.9% over the forecast period, due to increasing investments in pharmaceutical and biotech R&D. Rise in monoclonal antibody production and growing emphasis on downstream processing are fueling the market growth.
Regional analysis: North America dominated the global market in 2022, accounting for over 35% of the global market share. This is attributed to presence of large number of key pharmaceutical and biotech companies. Asia Pacific is expected to witness fastest growth during the forecast period due to expanding biopharmaceutical industry, increasing outsourcing of pharmaceutical manufacturing to countries like China and India, and rising R&D investments.
Key players related content comprises Key players operating in the Prepacked Chromatography Columns market are Thermo Fisher Scientific Inc., Cytiva, Sartorius AG, Repligen Corporation, Merck Millipore, VWR International, Llc. (Avantor), Phenomenex Inc., Agilent Technologies, Inc., Knauer Wissenschaftliche Geräte GmbH, Hawach Scientific Co., Ltd. Thermo Fisher and Cytiva dominate the market with their broad product portfolio and strong global presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.